1. Home
  2. VLRS vs GERN Comparison

VLRS vs GERN Comparison

Compare VLRS & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • GERN
  • Stock Information
  • Founded
  • VLRS 2005
  • GERN 1990
  • Country
  • VLRS Mexico
  • GERN United States
  • Employees
  • VLRS N/A
  • GERN N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLRS Consumer Discretionary
  • GERN Health Care
  • Exchange
  • VLRS Nasdaq
  • GERN Nasdaq
  • Market Cap
  • VLRS 676.8M
  • GERN 700.6M
  • IPO Year
  • VLRS N/A
  • GERN 1996
  • Fundamental
  • Price
  • VLRS $5.60
  • GERN $1.28
  • Analyst Decision
  • VLRS Strong Buy
  • GERN Buy
  • Analyst Count
  • VLRS 6
  • GERN 8
  • Target Price
  • VLRS $8.85
  • GERN $3.71
  • AVG Volume (30 Days)
  • VLRS 856.9K
  • GERN 10.8M
  • Earning Date
  • VLRS 07-21-2025
  • GERN 08-06-2025
  • Dividend Yield
  • VLRS N/A
  • GERN N/A
  • EPS Growth
  • VLRS N/A
  • GERN N/A
  • EPS
  • VLRS N/A
  • GERN N/A
  • Revenue
  • VLRS $3,019,191,000.00
  • GERN $164,447,000.00
  • Revenue This Year
  • VLRS N/A
  • GERN $159.14
  • Revenue Next Year
  • VLRS $12.85
  • GERN $52.76
  • P/E Ratio
  • VLRS N/A
  • GERN N/A
  • Revenue Growth
  • VLRS N/A
  • GERN 11877.20
  • 52 Week Low
  • VLRS $3.49
  • GERN $1.09
  • 52 Week High
  • VLRS $9.00
  • GERN $4.84
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 58.61
  • GERN 49.49
  • Support Level
  • VLRS $5.49
  • GERN $1.20
  • Resistance Level
  • VLRS $5.90
  • GERN $1.43
  • Average True Range (ATR)
  • VLRS 0.27
  • GERN 0.08
  • MACD
  • VLRS 0.02
  • GERN 0.02
  • Stochastic Oscillator
  • VLRS 74.52
  • GERN 55.88

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: